ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
01 1ChemWerth Inc
02 1LGM Pharma
03 1Rochem International Inc
04 1Faran Shimi Pharmaceutical
05 1HRV Global Life Sciences
06 1USV Private Limited
07 1Omgene Life Sciences Pvt. Ltd
08 1TAPI Technology & API Services
09 1Anthem Biosciences
10 1Auro Peptides Limited
11 1Aurobindo Pharma Limited
12 1BCN Peptides
13 1Chengdu Shengnuo Biopharm
14 1CordenPharma
15 1Guangzhou Tosun Pharmaceutical
16 2Hybio Pharmaceutical
17 1Jin Dun Medical
18 2MSN Laboratories
19 1Pellets Pharma Limited
20 1Piramal Pharma Solutions
21 2PolyPeptide Group
22 1Shenzhen JYMed Technology
23 1Smaart Pharmaceutticals
24 1Sun Pharmaceutical Industries Limited
25 1Teva Pharmaceutical Industries
26 1Viatris
27 1Blank
01 6China
02 1Germany
03 11India
04 1Iran
05 2Israel
06 1Spain
07 2Switzerland
08 5U.S.A
09 1Blank
01 11Active
02 1Inactive
03 18Blank
01 30Blank
01 1231MF10090
02 29Blank
01 1WC-0383A4
02 1WC-0443
03 28Blank
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-03-25
Pay. Date : 2016-02-12
DMF Number : 30274
Submission : 2016-03-10
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-12-23
Pay. Date : 2016-02-23
DMF Number : 30266
Submission : 2016-11-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24992
Submission : 2011-05-27
Status : Active
Type : II
Registration Number : 231MF10090
Registrant's Address : 2075 North 55th Street Boulder, Colorado 80301-2880, U.S. S. A
Initial Date of Registration : 2019-04-16
Latest Date of Registration : --
NDC Package Code : 12869-110
Start Marketing Date : 2012-08-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
We have 26 companies offering Linaclotide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?